Stock Scorecard



Stock Summary for Dexcom Inc (DXCM) - $84.51 as of 5/27/2025 12:39:12 PM EST

Total Score

7 out of 30

Safety Score

50 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DXCM

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DXCM

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DXCM

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for DXCM

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for DXCM (50 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for DXCM

Prediction: These 2 Stocks Will Beat the Market in the Next Decade 5/27/2025 7:46:00 AM
QGEN Stock Might Gain Following New Partnership With ID Solutions 5/23/2025 12:41:00 PM
2 Dividend Stocks to Buy With $500 and Hold Forever 5/23/2025 10:30:00 AM
Walgreens Opens New Micro-Fulfillment Center in Brooklyn Park 5/22/2025 12:26:00 PM
Should Tandem Diabetes Stock Stay in Your Portfolio Now? 5/22/2025 10:38:00 AM
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF ( RSPH ) ? 5/22/2025 10:20:00 AM
Neogen Stock Gains Following Strategic Alliance With Syngenta 5/20/2025 11:53:00 AM
The End Of The Diabetes Industry? - Eli Lilly ( NYSE:LLY ) , DexCom ( NASDAQ:DXCM ) 5/19/2025 3:57:00 PM
Here's Why You Should Add DexCom Stock to Your Portfolio Now 5/16/2025 12:00:00 PM
ALGN Stock Might Rise Following the NMPA Approval in China 5/16/2025 11:59:00 AM

Financial Details for DXCM

Company Overview

Ticker DXCM
Company Name Dexcom Inc
Country USA
Description DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 3/31/2025
Next Earnings Date 7/23/2025

Stock Price History

Last Day Price 84.51
Price 4 Years Ago 134.24
Last Day Price Updated 5/27/2025 12:39:12 PM EST
Last Day Volume 2,599,356
Average Daily Volume 4,060,338
52-Week High 128.63
52-Week Low 57.52
Last Price to 52 Week Low 46.92%

Valuation Measures

Trailing PE 63.54
Industry PE 38.71
Sector PE 39.78
5-Year Average PE 111.89
Free Cash Flow Ratio 36.58
Industry Free Cash Flow Ratio 36.59
Sector Free Cash Flow Ratio 31.33
Current Ratio Most Recent Quarter 1.50
Total Cash Per Share 2.31
Book Value Per Share Most Recent Quarter 5.78
Price to Book Ratio 14.62
Industry Price to Book Ratio 5.03
Sector Price to Book Ratio 31.86
Price to Sales Ratio Twelve Trailing Months 7.99
Industry Price to Sales Ratio Twelve Trailing Months 5.77
Sector Price to Sales Ratio Twelve Trailing Months 39.43
Analyst Buy Ratings 18
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 392,107,000
Market Capitalization 33,136,962,570
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.41%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -25.80%
Annual Earnings Growth 6.41%
Reported EPS 12 Trailing Months 1.33
Reported EPS Past Year 0.32
Reported EPS Prior Year 1.65
Net Income Twelve Trailing Months 535,200,000
Net Income Past Year 576,200,000
Net Income Prior Year 541,500,000
Quarterly Revenue Growth YOY 12.50%
5-Year Revenue Growth 22.27%
Operating Margin Twelve Trailing Months 12.90%

Balance Sheet

Total Cash Most Recent Quarter 904,900,000
Total Cash Past Year 606,100,000
Total Cash Prior Year 566,300,000
Net Cash Position Most Recent Quarter -333,100,000
Net Cash Position Past Year -630,900,000
Long Term Debt Past Year 1,237,000,000
Long Term Debt Prior Year 2,434,200,000
Total Debt Most Recent Quarter 1,238,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.65
Total Stockholder Equity Past Year 2,102,600,000
Total Stockholder Equity Prior Year 2,068,600,000
Total Stockholder Equity Most Recent Quarter 2,266,600,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 575,200,000
Free Cash Flow Per Share Twelve Trailing Months 1.47
Free Cash Flow Past Year 630,700,000
Free Cash Flow Prior Year 511,900,000

Options

Put/Call Ratio 0.31
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 3.64
MACD Signal 3.69
20-Day Bollinger Lower Band 61.43
20-Day Bollinger Middle Band 79.23
20-Day Bollinger Upper Band 97.03
Beta 1.44
RSI 58.94
50-Day SMA 81.06
150-Day SMA 101.56
200-Day SMA 105.62

System

Modified 5/26/2025 10:33:06 PM EST